Syllabus
AI Governance in Drug and Device Development Professional Certificate
36 lessons, about 14 hours. Online and self-paced.
Use-Case Definition and Triage
Define the deployed system, its intended role, and the regulatory questions that determine the evidence and approvals needed.
- 1AI Workflow Boundaries and Use Categories
- 2Context-of-Use Statement Workshop
- 3Risk Classification Across Regulatory Frameworks
- 4Regulatory Sources and Applicability Register
Drug Evidence Credibility
Apply FDA's proposed credibility framework to drug-development evidence while preserving clinical, safety, and quality responsibilities.
- 5FDA Drug-Model Credibility Framework
- 6Risk-Based Credibility Assessment Plans
- 7Clinical Investigation Protection Gates
- 8Credibility Plan Execution and Deviations
- 9Credibility Results and Adequacy Decisions
- 10Seven-Step Credibility Assessment Workshop
- 11International Drug Lifecycle Alignment
Data and Assurance Evidence
Evaluate whether data, performance testing, privacy controls, and reproducible records support the proposed AI use.
- 12Data Provenance and Evaluation Fitness
- 13GDPR Processing and Model Anonymity
- 14HIPAA Research Data Access
- 15Performance and Human-System Evaluation
- 16Generative System and Supplier Assurance
- 17Reproducible Assurance Package Review
Device Lifecycle and Change
Determine device obligations, draft bounded change plans, and route postmarket safety and cybersecurity findings through the quality system.
- 18Device Function Qualification
- 19QMSR Design and Development Controls
- 20Production and QMS Software Assurance
- 21PCCP Content and Modification Boundaries
- 22PCCP Drafting and Change Decisions
- 23Device Monitoring and Reportability Decisions
- 24Cyber-Device Security and Response
EU AI Act Decisions
Classify systems and organizational roles, then create a dated compliance plan under the amended EU AI Act.
- 25Territorial Scope and Operator Roles
- 26Prohibited Practice Screening
- 27Product and Internal-Tool Applicability Matrix
- 28Provider and Deployer Evidence
- 29Literacy and Transparency Controls
- 30EU Commencement and Transition Calendar
GxP Governance and Readiness
Integrate current computerized-system controls, draft-guidance readiness, and accountable operations into a proportionate governance policy.
- 31Manufacturing Equipment and Electronic Records
- 32Current Annex 11 Lifecycle Controls
- 33Draft Annex 22 Readiness Assessment
- 34GxP Governance Policy Workshop
- 35Monitoring and Regulatory Intelligence Operations
- 36Governance Portfolio and Final Assessment




























